The FDA has approved the first at-home brain stimulation device for treating depression. Flow Neuroscience’s FL-100 delivers ...
SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a ...
An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the ...
FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).
Midtown mental health clinic Radial Health, which offers less common treatments for mental illnesses, such as electromagnetic therapy and fast-acting medications, raised a $50 million Series A this ...
McLeod Software’s latest version of its transportation management solutions for freight brokers and motor carriers is “a completely re-engineered user interface and workflows for trucking operations,” ...
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with ...
Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback